NCT05319873 Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05303285 A Study Evaluating the Efficacy of Secukinumab 300mg in Chinese Adults With Active Ankylosing Spondylitis Status RECRUITING Phase PHASE4
NCT05296746 Neoadjuvant and Adjuvant Ribociclib and ET for Clinically High-risk ER+ and HER2- Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05286164 Eltrombopag Treatment in Patients With Prolonged BM Toxicity After CART Status UNKNOWN Phase PHASE2
NCT05285917 Promoting Utilization and Safety of Hydroxyurea Using Precision in Africa Status RECRUITING Phase PHASE3
NCT05243641 Neratinib and Capmatinib Combination (Phase Ib/II) in Metastatic Breast Cancer and Inflammatory Breast Cancer Patients With Abnormal HER-family and c-Met Pathway Activity as Measured by the CELsignia Signaling Analysis Test Status TERMINATED Phase PHASE1/PHASE2
NCT05230810 Clinical Trial of Alpelisb and Tucatinib in Patients With PIK3CA-Mutant HER2+ Metastatic Breast Cancer. Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05210413 Spartalizumab and Low-dose PAzopanib in Refractory or Relapsed Solid TumOrs of Pediatric and Adults Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05207709 Ribociclib vs. Palbociclib in Patients With Advanced Breast Cancer Within the HER2-Enriched Intrinsic Subtype Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05199961 Quality of Life of Adults With Diffuse Large B-cell Lymphoma Treated With Tisagenlecleucel Status TERMINATED Phase NA
NCT05198479 Phase II 177Lu-DOTATATE Study in Metastatic NPC With a Safety Run-in Status SUSPENDED Phase PHASE2
NCT05180695 HDM201 and Pazopanib in Patients With P53 Wild-type Advanced/Metastatic Soft Tissue Sarcomas Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05171374 pRospective Evaluation of Clinical Outcomes in Patients With metAsTatIс melanOma Treated With dabrafeNib and trAmetinib in reaL practicE Status UNKNOWN Phase N/A
NCT05163106 Neoadjuvant Treatment of Locally-advanced Breast Cancer Patients With Ribociclib and Letrozole Status COMPLETED Phase PHASE2
NCT05154487 A Study of Alpelisib and Fulvestrant to Treat Endometrial Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05154344 RW Effectiveness of Capmatinib in Advanced MET-dysregulated NSCLC Included in the French Compassionate Use Program (ATU) Status COMPLETED Phase N/A
NCT05085249 Improving Goal Directed Medical Therapy for Device Clinic Patients With Reduced EF at UOHI: a QI Initiative (VIGILANT) Status COMPLETED Phase N/A